 PREDICTORS OF TREATMENT RESPONSE TO AFLIBERCEPT AND AQUEOUS CYTOKINE LEVELS IN PATIENTS WITH PERSISTENT DIABETIC MACULAR EDEMA FOLLOWING TREATMENT WITH RANIBIZUMAB: AN INTERVENTIONAL PROSPECTIVE STUDY: 